Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


August 04, 2015 12:15 AM ET

Pharmaceuticals

Company Overview of Johnson & Johnson

Executive Profile

Alastair John Tanton Clemow Ph.D., MBA

Executive Officer, Johnson & Johnson
AgeTotal Calculated CompensationThis person is connected to 5 Board Members in 5 different organizations across 12 different industries.

See Board Relationships
63--

Background

Dr. Alastair John Tanton Clemow, Phd, MBA, serves as the President and Chief Executive Officer of Regentis Biomaterials Ltd. Dr. Clemow serves as an Advisor of Kinetic Muscles, Inc. He has more than 25 years of experience in the development and management of orthopaedic devices and also has over 30 years of senior management experience within healthcare companies. Dr. Clemow served as the President and Chief Executive Officer of Nexgen Spine Inc., from 2004 to 2009. ...

Corporate Headquarters

One Johnson & Johnson Plaza
New Brunswick, New Jersey 08933

United States

Phone: 732-524-0400
Fax: --

Board Members Memberships

Director
Advisor and Director
Director
2010-Present
Director, Chairman of Compensation Committee, Member of Audit Committee and Member of Nominating & Corporate Governance Committee
2011-Present
Director

Education

MBA
Columbia University
PhD
University of Surrey
BS
University of Surrey

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

There is no Total Compensation data available.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Alan George Lafley Chairman, Chief Executive Officer, President and Member of Proxy Committee
The Procter & Gamble Company
$6.4M
Ian C. Read Chairman, Chief Executive Officer and Chairman of Executive Committee
Pfizer Inc.
$1.8M
Jeffrey R. Immelt Executive Chairman and Chief Executive Officer
General Electric Company
$9.2M
Joseph Jimenez Jr., MBAChief Executive Officer
Novartis AG
$6.1M
Severin Schwan Ph.D.Chief Executive Officer and Director
Roche Holding AG
$5.3M
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Johnson & Johnson, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.